Private equity firm Warburg Pincus acquired a majority stake in contact sterilization provider Sterigenics International, according to GTCR, which bought the company in 2011.
Warburg Pincus takes majority stake in Sterigenics
Warburg Pincus LLC
Is Valeant About To Make A Bold Bid For Bausch & Lomb?
Never let it be said that Valeant (NYSE: VRX) management is shy about doing deals. With a roster of past deals including Biovail, Cephalon, OraPharma, and Medicis, Valeant claims that better than 80% of its deals have attained the 20% internal return target it uses to evaluate potential transactions. If rumors out Friday prove true, Valeant is about to bag its biggest target yet in what would be a particularly bold move.
